SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F99906CC905933A6D5348147CC72FC8D007FA308D05774577BB36E04CE04AE555EFBFFD3751B61DD916C2CAD4412DA86>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F99906CC905933A6D5348147CC72FC8D007FA308D05774577BB36E04CE04AE555EFBFFD3751B61DD916C2CAD4412DA86
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F99906CC905933A6D5348147CC72FC8D007FA308D05774577BB36E04CE04AE555EFBFFD3751B61DD916C2CAD4412DA86
http://www.w3.org/2000/01/rdf-schema#comment
"Data indicate positive staining was observed for both A33 expression and KRN330 binding from patients biopsied on Day 8 9 or 14 following initial dosing of 3 mg/kg."
xsd:string
http://purl.uniprot.org/uniprot/#_65C9481CCFA48B2B8C2D8458B649A1E9AD4517158C96308D1A4544E284BF0AB79452536A076DBC7CA9248C3BB879EB7A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F99906CC905933A6D5348147CC72FC8D007FA308D05774577BB36E04CE04AE555EFBFFD3751B61DD916C2CAD4412DA86
http://purl.uniprot.org/uniprot/Q99795
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F99906CC905933A6D5348147CC72FC8D007FA308D05774577BB36E04CE04AE555EFBFFD3751B61DD916C2CAD4412DA86
http://purl.uniprot.org/uniprot/#_Q99795-mappedCitation-23294608
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F99906CC905933A6D5348147CC72FC8D007FA308D05774577BB36E04CE04AE555EFBFFD3751B61DD916C2CAD4412DA86